Cortical Binding of Pittsburgh Compound B, an Endophenotype for Genetic Studies of Alzheimer's Disease
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 67 (6) , 581-583
Abstract
No abstract availableKeywords
Funding Information
- National Center for Research Resources
- McDonnell Center for Systems Neuroscience
This publication has 20 references indexed in Scilit:
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseNeuropsychologia, 2008
- CSF tau/Aβ 42 ratio for increased risk of mild cognitive impairmentNeurology, 2007
- Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2007
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humansAnnals of Neurology, 2006
- A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volumeNeuroImage, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Robust asymptotic sampling theory for correlations in pedigreesStatistics in Medicine, 2003
- Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging AgentsJournal of Medicinal Chemistry, 2003
- Multipoint Oligogenic Analysis of Age-at-Onset Data with Applications to Alzheimer Disease PedigreesThe American Journal of Human Genetics, 1999